Literature DB >> 2731316

Influence of site on the chemosensitivity of transplantable murine colon tumours to flavone acetic acid (LM975, NSC 347512).

M C Bibby1, R M Phillips, J A Double.   

Abstract

A number of experimental studies have demonstrated significant responses of s.c. solid tumours to flavone acetic acid (FAA). Clinical studies to date have been disappointing, with no objective responses being seen. The present study demonstrated that the tumour site is important for the anti-tumour action of FAA against two transplantable adenocarcinoma lines (MAC) in NMRI mice. Responses were achievable only when the tumours were implanted s.c. Ascitic or systemic tumours did not respond to FAA. Experimentally achievable plasma levels of FAA were not sufficient to induce significant cell kills in either MAC 15A or MAC 26 cell lines in vitro. A poor correlation exists between in vitro and in vivo responses, as the clonogenic assay could not predict the response of the solid MAC tumours grown s.c. The in vitro data indicated that the length of exposure to FAA was important, with long exposure times being necessary for cytotoxicity to develop, in these tumour cell lines. These studies imply that more than one mechanism is involved, and it is likely that the activity of FAA against s.c. tumours relies at least in part on a specific biological feature of tumours in this site. However, it may still be possible to achieve systemic tumour cell kill in vivo by increasing drug-exposure times.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2731316     DOI: 10.1007/bf00263126

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  14 in total

1.  Experimental anti-tumor effects of flavone acetic acid (LM975).

Authors:  M C Bibby; J A Double; R M Phillips; P M Loadman; J A Gummer
Journal:  Prog Clin Biol Res       Date:  1988

2.  Flavone acetic acid (NSC 347512) induces haemorrhagic necrosis of mouse colon 26 and 38 tumours.

Authors:  G P Smith; S B Calveley; M J Smith; B C Baguley
Journal:  Eur J Cancer Clin Oncol       Date:  1987-08

3.  Transplantation of adenocarcinomas of the colon in mice.

Authors:  J A Double; C R Ball; P N Cowen
Journal:  J Natl Cancer Inst       Date:  1975-01       Impact factor: 13.506

4.  In vitro chemosensitivity testing of flavone acetic acid (LM975; NSC 347512) and its diethylaminoethyl ester derivative (LM985; NSC 293015).

Authors:  W A Schroyens; P F Dodion; C Sanders; M Loos; N E Dethier; A R Delforge; P A Stryckmans; Y Kenis
Journal:  Eur J Cancer Clin Oncol       Date:  1987-08

5.  Antiproliferative properties of flavone acetic acid (NSC 347512) (LM 975), a new anticancer agent.

Authors:  L S Capolongo; G Balconi; P Ubezio; R Giavazzi; G Taraboletti; A Regonesi; O C Yoder; M D'Incalci
Journal:  Eur J Cancer Clin Oncol       Date:  1987-10

6.  Phase I and pharmacokinetic study of flavone acetic acid.

Authors:  D J Kerr; S B Kaye; J Cassidy; C Bradley; E M Rankin; L Adams; A Setanoians; T Young; G Forrest; M Soukop
Journal:  Cancer Res       Date:  1987-12-15       Impact factor: 12.701

7.  Activity of flavone acetic acid (NSC-347512) against solid tumors of mice.

Authors:  T H Corbett; M C Bissery; A Wozniak; J Plowman; L Polin; E Tapazoglou; J Dieckman; F Valeriote
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

8.  Primary bioassay of human tumor stem cells.

Authors:  A W Hamburger; S E Salmon
Journal:  Science       Date:  1977-07-29       Impact factor: 47.728

9.  Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid).

Authors:  M C Bibby; J A Double; R M Phillips; P M Loadman
Journal:  Br J Cancer       Date:  1987-02       Impact factor: 7.640

10.  The effects of melphalan and misonidazole on the vasculature of a murine sarcoma.

Authors:  J C Murray; V Randhawa; J Denekamp
Journal:  Br J Cancer       Date:  1987-03       Impact factor: 7.640

View more
  10 in total

1.  Flavone acetic acid antitumour activity against a mouse pancreatic adenocarcinoma is mediated by natural killer cells.

Authors:  G Damia; G Tagliabue; P Allavena; M D'Incalci
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

2.  The use of vascularised spheroids to investigate the action of flavone acetic acid on tumour blood vessels.

Authors:  L J Zwi; B C Baguley; J B Gavin; W R Wilson
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

3.  Flavone acetic acid--an interesting novel therapeutic agent or just another disappointment?

Authors:  M C Bibby
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

4.  Divergent effects of flavone acetic acid on established versus developing tumour blood flow.

Authors:  V Mahadevan; I R Hart
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

5.  In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug.

Authors:  K Grosios; S E Holwell; A T McGown; G R Pettit; M C Bibby
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

6.  Differential efficacy of flavone acetic against liver versus lung metastases in a human tumour xenograft.

Authors:  G Pratesi; C Manzotti; M Tortoreto; R A Audisio; F Zunino
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

7.  The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumours.

Authors:  P K Quinn; M C Bibby; J A Cox; S M Crawford
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

8.  Anti-tumour activity of flavone acetic acid (NSC 347512) in mice--influence of immune status.

Authors:  M C Bibby; R M Phillips; J A Double; G Pratesi
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

9.  Preclinical in vitro and in vivo activity of 5,6-dimethylxanthenone-4-acetic acid.

Authors:  A L Laws; A M Matthew; J A Double; M C Bibby
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640

10.  DMXAA causes tumor site-specific vascular disruption in murine non-small cell lung cancer, and like the endogenous non-canonical cyclic dinucleotide STING agonist, 2'3'-cGAMP, induces M2 macrophage repolarization.

Authors:  Charlene M Downey; Mehrnoosh Aghaei; Reto A Schwendener; Frank R Jirik
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.